GlassScriptPhysician profile
Valorie Omara
NPI 1568648418
$4,287.10
in general payments reported to CMS, 2019-2025
32 companies · $970 in 2025
The $970 reported for 2025 was more than what 84% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $234 · 2022: $641 · 2023: $1,146 · 2024: $1,297 · 2025: $970.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,412.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,412.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $569.01 | 2022-2025 | Verquvo, Capvaxive |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $398.77 | 2021-2025 | Lifevest |
| Esperion Therapeutics, INC. | $342.57 | 2022-2025 | Nexletol, Nexlizet |
| Impulse Dynamics (USA) INC. | $341.95 | 2022-2024 | Optimizer, Optimizer |
| Boston Scientific Corporation | $339.51 | 2023-2025 | Watchman Access System, Watchman Flx |
| Amgen INC. | $299.41 | 2022-2024 | Repatha |
| Novartis Pharmaceuticals Corporation | $222.45 | 2022-2025 | |
| Pfizer INC. | $217.08 | 2022-2025 | |
| Janssen Pharmaceuticals, INC | $215.34 | 2021-2024 | Xarelto |
| Bayer Healthcare Pharmaceuticals INC. | $196.62 | 2022-2025 | |
| Abbott Laboratories | $105.06 | 2021-2025 | Jot Dx, Aveir |
| Medicure Pharma INC. | $104.73 | 2023 | Zypitamag |
| E.R. Squibb & Sons, L.L.C. | $101.53 | 2021-2025 | Camzyos |
| Heartflow, INC. | $100.79 | 2024-2025 | |
| Cvrx, INC. | $80.27 | 2024-2025 | Barostim Neo System |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kiniksa Pharmaceuticals, LTD. | $76.37 | 2023 | Arcalyst |
| Scpharmaceuticals INC. | $73.79 | 2025 | |
| Baxter Healthcare | $67.82 | 2022-2025 | Hillrom - Carnation Ambulatory Monitor |
| Kiniksa Pharmaceuticals International, Plc | $65.45 | 2024 | Arcalyst |
| Edwards Lifesciences Corporation | $65.30 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $56.22 | 2024-2025 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $33.82 | 2023 | |
| Novo Nordisk INC | $33.48 | 2025 | Wegovy |
| Actelion Pharmaceuticals US, INC. | $28.91 | 2023 | Opsumit |
| Lexicon Pharmaceuticals, INC. | $26.95 | 2024 | |
| Daiichi Sankyo INC. | $21.86 | 2023 | Injectafer |
| Chiesi USA, INC. | $20.70 | 2024 | Juxtapid |
| Kowa Pharmaceuticals America, INC. | $20.06 | 2023 | Livalo |
| Silk Road Medical, INC. | $18.18 | 2021 | |
| Bridgebio Pharma, INC. | $15.67 | 2025 | Attruby |
| Bardy Diagnostics, INC. | $14.65 | 2022 | |
| Hologic Sales and Service, LLC | $12.78 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Valorie Omara listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.